JSAM
OLMA icon

J. Safra Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

J. Safra Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.07K Buy
+273
New +$6.08K ﹤0.01% 507

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

J. Safra Asset Management's OLMA Position: Q1 2026 in Review

J. Safra Asset Management opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 273 shares worth $4.07K. The stake represents ﹤0.01% of the portfolio and ranks #507 among its holdings.

195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • J. Safra Asset Management held 273 shares of Olema Pharmaceuticals worth $4.07K as of Q1 2026.
  • Olema Pharmaceuticals was a new J. Safra Asset Management position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of J. Safra Asset Management's portfolio in Q1 2026, its #507 holding.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.